We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA issues draft guidance concerning unsolicited requests for off-label information and seeks comments concerning scientific exchange of information

09 January 2012

Medical Device Alert

On December 28, 2011, the U.S. Food and Drug Administration (FDA or "the Agency") published a Federal Register notice requesting comments and information1 to assist with its evaluation of FDA policies pertaining to communications and activities related to unapproved ("off-label") uses of marketed products, as well as those related to products that are not legally marketed in the United States for any use. In particular, the Agency seeks to obtain comments and information related to "scientific exchange."

Read "FDA issues draft guidance concerning unsolicited requests for off-label information and seeks comments concerning scientific exchange of information"

The team

Loading data